Sign in to continue:

Sunday, July 26th, 2026

Duos Technologies Group, Inc. Elects Douglas Recker to Board of Directors – SEC Form 8-K Filing May 2026

NIL
Disclaimer:
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research and consult with a qualified financial advisor before making investment decisions. The information provided is based on the company’s Form 8-K filing dated May 14, 2026, and no material, price-sensitive, or market-moving events were disclosed in this report.

View DUOS TECHNOLOGIES GROUP, INC. Historical chart here



Passage Bio and Remix Therapeutics Announce Merger to Advance RNA-Targeted Cancer Therapies with $100M Financing

Passage Bio and Remix Therapeutics Announce Transformational...

Novanta Inc. 2025 Annual Report: 10-K Filing Highlights, Financials, and Company Information

Novanta Inc. FY2025 10-K Detailed Investor Analysis Nova...